Quick Answer
CANNAPHARMARX, INC. reported Total Revenue of $1.36 million for the year ending 2025.
- CANNAPHARMARX, INC. showed an increase of +66.1% in Total Revenue from 2024 to 2025.
- This data is from CANNAPHARMARX, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $0.00 | Q2 2014: $0.00 | Q3 2014: $0.00 | Q1 2015: $0.00 | Q2 2015: $0.00 | Q3 2015: $0.00 | Q1 2016: $0.00 | Q2 2016: $0.00 | Q3 2016: $0.00 | Q1 2017: $0.00 | Q2 2017: $0.00 | Q3 2017: $0.00 | Q1 2018: $0.00 | Q2 2018: $0.00 | Q3 2018: $0.00 | Q1 2019: $0.00 | Q2 2019: $0.00 | Q3 2019: $0.00 | Q1 2020: $0.00 | Q2 2020: $0.00 | Q3 2020: $0.00 | Q1 2021: $0.00 | Q2 2021: $0.00 | Q3 2021: $0.00 | Q1 2022: $0.00 | Q2 2022: $0.00 | Q3 2022: $0.00 | Q1 2023: $0.00 | Q2 2023: $0.00 | Q3 2023: $0.00 | Q1 2024: $25.8 thousand | Q2 2024: $0.00 | Q3 2024: $312.2 thousand | Q1 2025: $335.3 thousand | Q2 2025: $231.6 thousand | Q3 2025: $656.6 thousand.
- Historical annual values: Fiscal year 2025: $1.36 million | Fiscal year 2024: $820.1 thousand | Fiscal year 2023: $0.00 | Fiscal year 2022: $0.00 | Fiscal year 2021: $0.00 | Fiscal year 2020: $0.00 | Fiscal year 2019: $0.00 | Fiscal year 2018: $0.00 | Fiscal year 2017: $0.00 | Fiscal year 2016: $0.00 | Fiscal year 2015: $0.00 | Fiscal year 2014: $0.00 | Fiscal year 2013: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: